238 related articles for article (PubMed ID: 9717954)
1. Tamoxifen in early breast cancer.
Saibara T; Ogawa Y; Onishi S
Lancet; 1998 Aug; 352(9125):404. PubMed ID: 9717954
[No Abstract] [Full Text] [Related]
2. Tamoxifen in early breast cancer.
Bryce CJ
Lancet; 1998 Aug; 352(9125):403. PubMed ID: 9717952
[No Abstract] [Full Text] [Related]
3. [Tamoxifen and breast cancer: is everything known already?].
Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
[No Abstract] [Full Text] [Related]
4. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
Obwegeser R; Auerbach L; Kubista E
Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
[No Abstract] [Full Text] [Related]
5. Tamoxifen therapy--long-term results and complications.
Moore MP; Kinne DW
Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
[No Abstract] [Full Text] [Related]
6. Tamoxifen.
Nurs Times; 2006 Feb 21-27; 102(8):33. PubMed ID: 16519033
[No Abstract] [Full Text] [Related]
7. Tamoxifen and menopausal status: risks and benefits.
Sasco AJ
Lancet; 1996 Mar; 347(9003):761. PubMed ID: 8602018
[No Abstract] [Full Text] [Related]
8. The duration of adjuvant tamoxifen therapy.
Bilimoria MM; Jordan VC
Cancer Treat Res; 1998; 94():181-93. PubMed ID: 9587688
[No Abstract] [Full Text] [Related]
9. Should tamoxifen users be screened for endometrial lesions?
Neven P; Vergote I
Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
[No Abstract] [Full Text] [Related]
10. Tamoxifen debate hinges on whose risk is high enough.
Reynolds T
J Natl Cancer Inst; 1998 Oct; 90(19):1428-30. PubMed ID: 9776407
[No Abstract] [Full Text] [Related]
11. Second cancers after adjuvant tamoxifen therapy for breast cancer.
Curtis RE; Boice JD; Shriner DA; Hankey BF; Fraumeni JF
J Natl Cancer Inst; 1996 Jun; 88(12):832-4. PubMed ID: 8637050
[No Abstract] [Full Text] [Related]
12. Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.
Rouanet P; Linares-Cruz G; Dravet F; Poujol S; Gourgou S; Simony-Lafontaine J; Grenier J; Kramar A; Girault J; Le Nestour E; Maudelonde T
J Clin Oncol; 2005 May; 23(13):2980-7. PubMed ID: 15860853
[TBL] [Abstract][Full Text] [Related]
13. One step forward or one step back with tamoxifen?
Gelmon K
Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
[No Abstract] [Full Text] [Related]
14. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Howell A; Cuzick J; Baum M; Buzdar A; Dowsett M; Forbes JF; Hoctin-Boes G; Houghton J; Locker GY; Tobias JS;
Lancet; 2005 Jan 1-7; 365(9453):60-2. PubMed ID: 15639680
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen's impact on the management of breast cancer: patient perspectives.
Reichman BS
Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):55-8. PubMed ID: 9065929
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in cancer therapy: minireview.
Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
[TBL] [Abstract][Full Text] [Related]
17. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
18. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
Powles TJ
J Natl Cancer Inst; 1999 Apr; 91(8):730. PubMed ID: 10218518
[No Abstract] [Full Text] [Related]
19. Should you be taking tamoxifen?
Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
[No Abstract] [Full Text] [Related]
20. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
